Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biogen -- Ignore unavailable to you. Want to Upgrade?

To: Biomaven who wrote (998)	6/9/1999 5:12:00 PM
From: P.M.Freedman	Read Replies (1) \| Respond to of 1686

In February, Biogen announced a repurchase of 4 million shares of BGEN over the next two years. Based on the 10Q ended in March, Biogen already purchased 500,000 shares in a month period. The average prices they paid were around $100/sh or totally $48.8 million. It was more than what they earned in last whole quarter (45.7 million). It looks like Biogen wanted to reduce the outstanding shares for better numbers badly in last quarter. Let's see how will it be in this quarter.